SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4jn2'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HUO_A_PNNA302_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	4jn2	ANTI DABIGATRAN FAB (Mus musculus)	4 / 6	LEU B 199 GLY B 200 ALA B 135 PRO B 136	None	0.52A	3huoA-4jn2B: undetectable	3huoA-4jn2B: 22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LAK_I_BEZI1_0 (3CL PROTEASE BEZ-TYR-TYR-ASN-ECC PEPTIDE INHIBITOR)	4jn2	ANTI DABIGATRAN FAB (Mus musculus)	3 / 3	SER B 103 TYR B 102 TYR B 101	None	0.52A	5lakA-4jn2B: undetectable 5lakI-4jn2B: undetectable	5lakA-4jn2B: 21.84 5lakI-4jn2B: 3.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LAK_J_BEZJ1_0 (3CL PROTEASE BEZ-TYR-TYR-ASN-ECC PEPTIDE INHIBITOR)	4jn2	ANTI DABIGATRAN FAB (Mus musculus)	3 / 3	SER B 103 TYR B 102 TYR B 101	None	0.47A	5lakC-4jn2B: undetectable 5lakJ-4jn2B: undetectable	5lakC-4jn2B: 21.84 5lakJ-4jn2B: 3.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5MTH_A_ACTA302_0 (ANTIBODY FAB HEAVY CHAIN)	4jn2	ANTI DABIGATRAN FAB (Mus musculus)	4 / 5	SER B 122 ALA B 124 PHE B 156 LEU B 180	None	0.38A	5mthA-4jn2B: 25.3	5mthA-4jn2B: 55.11

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["3HUO_A_PNNA302_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","4jn2","ANTI DABIGATRAN FAB","Mus musculus",4,"LEU B 199;GLY B 200;ALA B 135;PRO B 136","None","0.52A","3huoA-4jn2B:undetectable","3huoA-4jn2B:22.51"],["5LAK_I_BEZI1_0","3CL PROTEASE;BEZ-TYR-TYR-ASN-ECC PEPTIDE INHIBITOR","4jn2","ANTI DABIGATRAN FAB","Mus musculus",3,"SER B 103;TYR B 102;TYR B 101","None","0.52A","5lakA-4jn2B:undetectable;5lakI-4jn2B:undetectable","5lakA-4jn2B:21.84;5lakI-4jn2B:3.51"],["5LAK_J_BEZJ1_0","3CL PROTEASE;BEZ-TYR-TYR-ASN-ECC PEPTIDE INHIBITOR","4jn2","ANTI DABIGATRAN FAB","Mus musculus",3,"SER B 103;TYR B 102;TYR B 101","None","0.47A","5lakC-4jn2B:undetectable;5lakJ-4jn2B:undetectable","5lakC-4jn2B:21.84;5lakJ-4jn2B:3.51"],["5MTH_A_ACTA302_0","ANTIBODY FAB HEAVY CHAIN","4jn2","ANTI DABIGATRAN FAB","Mus musculus",4,"SER B 122;ALA B 124;PHE B 156;LEU B 180","None","0.38A","5mthA-4jn2B:25.3","5mthA-4jn2B:55.11"]]